Please, Signup (Login) to subscribe or trade (demo)
Allergan plc. stock price
Allergan plc. latest news:
Sarepta Therapeutics names new CEO
Drugmaker Sarepta Therapeutics Inc. on Wednesday named Douglas Ingram its next chief executive. Ingram, currently the president and CEO at Allergan PLC's Chase Pharmaceutics, will start Sept. 20, Sarepta said. He replaces Edward Kaye, who took over as interim chief executive in 2015. Last year, Sarepta won government approval for its Duchenne muscular dystrophy drug.Market Pulse Stories are Rapid-fire, short news bursts on stocks and markets as they move. Visit MarketWatch.com for more information on this news.